CEO congratulates recipient of GlaxoSmithKline Award for Research Excellence

ARCHIVED CONTENT – For reference purposes only

NHMRC congratulates Professor Chris Goodnow for his GlaxoSmithKline Award for Research Excellence to further develop his world-leading research on the cause of autoimmune diseases.

NHMRC is an ongoing supporter of Professor Goodnow research. In 2010 Professor he was awarded a $4 million NHMRC Australia Fellowship to identify the root cause of auto-immune disease. Commencing this year, Professor Goodnow and his team were awarded a $15.7 million

to research the molecular and cellular basis of inflammatory and immunodeficiency diseases.

For more information on the GlaxoSmithKline Award, visit this website.